Senescence-directed nanotherapy ameliorates fibrosis and overcomes immune exclusion in cancer
Clemens Hinterleitner, Valentin J.A. Barthet, Hailey V. Goldberg…·Scott W. Lowe
P-selectin-targeted fucoidan nanoparticles carrying Navitoclax or dBET6 deplete a senescent-like, lipid-associated macrophage subset, reverse mouse liver and lung fibrosis with less toxicity, and restore checkpoint therapy response in fibrotic tumors.